How many drugs for LUTS due to BPH are too many?
Andersson
Karl-Erik
KE
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D017292:Doxazosin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D000077409:Tamsulosin; D000068737:Tolterodine Tartrate; D014227:Triazines / Q000627:therapeutic use; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D000069058:Vardenafil Dihydrochloride
D000317:Adrenergic alpha-Antagonists; D001559:Benzhydryl Compounds; D003408:Cresols; D004791:Enzyme Inhibitors; D007093:Imidazoles; D018727:Muscarinic Antagonists; D010879:Piperazines; D013449:Sulfonamides; D013450:Sulfones; D014227:Triazines; D010665:Phenylpropanolamine; D018120:Finasteride; D000069058:Vardenafil Dihydrochloride; D000068737:Tolterodine Tartrate; D000077409:Tamsulosin; D017292:Doxazosin